Clinical Trials
9 trialsNCT06124131 2025-05-04
BENEFIT-C
Tulane University
Phase NA Completed
NCT02860039 2024-10-22
High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant
Vanderbilt-Ingram Cancer Center
Phase 2 Completed
NCT00965354 2024-09-19
MOSAIC
Imperial College London
Completed
NCT02566265 2019-01-30
SHIVERING 2
Yale University
Phase 2 Completed
NCT01924169 2018-09-20
Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT01215981 2017-12-28
Influenza Vaccine Post Allogeneic Transplant
Masonic Cancer Center, University of Minnesota
Phase NA Terminated
NCT00112112 2017-08-14
Safety Study to Evaluate FluMist in Immunocompromised Children
MedImmune LLC
Phase 1 Completed
NCT01205581 2016-09-23
Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV
St. Jude Children's Research Hospital
Phase 2 Completed
NCT01666782 2016-06-24
IMMUNE
Rochester General Hospital
Phase 2 Completed